JPMORGAN CHASE & CO - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,646,575
-21.1%
302,124
-2.9%
0.00%
Q2 2023$2,088,125
-54.9%
311,196
-40.6%
0.00%
-100.0%
Q1 2023$4,625,000
+149916.2%
523,748
+29.8%
0.00%
Q4 2022$3,083
-99.9%
403,395
-25.9%
0.00%
-100.0%
Q3 2022$3,876,000
-14.6%
544,244
-3.0%
0.00%0.0%
Q2 2022$4,538,000
-0.7%
560,788
+70.4%
0.00%0.0%
Q1 2022$4,569,000
-41.8%
329,115
+17.7%
0.00%0.0%
Q4 2021$7,847,000
+25.9%
279,664
+52.5%
0.00%0.0%
Q3 2021$6,233,000
-22.7%
183,384
-7.1%
0.00%0.0%
Q2 2021$8,064,000
-85.6%
197,343
-85.8%
0.00%
-85.7%
Q1 2021$55,906,000
-28.7%
1,388,633
+4.7%
0.01%
-41.7%
Q4 2020$78,409,000
+15.2%
1,326,067
-6.4%
0.01%
+9.1%
Q3 2020$68,087,000
+60.1%
1,417,291
+61.3%
0.01%
+37.5%
Q2 2020$42,519,000
+126.7%
878,873
+30.2%
0.01%
+100.0%
Q1 2020$18,754,000
+36.4%
675,120
+46.9%
0.00%
+33.3%
Q4 2019$13,747,000
-48.9%
459,440
-47.2%
0.00%
-40.0%
Q3 2019$26,905,000
+75.6%
870,724
+129.0%
0.01%
+66.7%
Q2 2019$15,323,000380,2280.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders